Coastal Investment Advisors, Inc. Ionis Pharmaceuticals Inc Transaction History

Coastal Investment Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 23, 2020	SELL	$47.45 - $62.95 $260,358 - $345,406	-5,487 Closed	0 $0
Q2 2020 Jul 16, 2020	SELL	$46.85 - $61.05 $213,167 - $277,777	-4,550 Reduced 45.33%	5,487 $324,000
Q1 2020 Apr 23, 2020	SELL	$41.6 - $63.4 $57,200 - $87,175	-1,375 Reduced 12.05%	10,037 $475,000
Q4 2019 Feb 05, 2020	BUY	$53.85 - $65.27 $22,832 - $27,674	424 Added 3.86%	11,412 $729,000
Q3 2019 Oct 18, 2019	BUY	$59.06 - $72.15 $56,992 - $69,624	965 Added 9.63%	10,988 $654,000
Q2 2019 Aug 01, 2019	BUY	$62.09 - $86.14 $10,679 - $14,816	172 Added 1.75%	10,023 $640,000
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $521,314 - $799,605	9,851 New	9,851 $795,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.1B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.